Saltar al contenido
Merck

Fingerprinting of psychoactive drugs in zebrafish anxiety-like behaviors.

PloS one (2014-08-01)
Caio Maximino, Annanda Waneza Batista da Silva, Juliana Araújo, Monica Gomes Lima, Vanessa Miranda, Bruna Puty, Rancés Benzecry, Domingos Luiz Wanderley Picanço-Diniz, Amauri Gouveia, Karen Renata Matos Oliveira, Anderson Manoel Herculano
RESUMEN

A major hindrance for the development of psychiatric drugs is the prediction of how treatments can alter complex behaviors in assays which have good throughput and physiological complexity. Here we report the development of a medium-throughput screen for drugs which alter anxiety-like behavior in adult zebrafish. The observed phenotypes were clustered according to shared behavioral effects. This barcoding procedure revealed conserved functions of anxiolytic, anxiogenic and psychomotor stimulating drugs and predicted effects of poorly characterized compounds on anxiety. Moreover, anxiolytic drugs all decreased, while anxiogenic drugs increased, serotonin turnover. These results underscore the power of behavioral profiling in adult zebrafish as an approach which combines throughput and physiological complexity in the pharmacological dissection of complex behaviors.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
N-Methyl-D-aspartic acid, ≥98% (TLC), solid
Sigma-Aldrich
Diazepam
Supelco
Diazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Sodium Nitroprusside, Pharmaceutical Secondary Standard; Certified Reference Material
Diazepam, European Pharmacopoeia (EP) Reference Standard
Diazepam for system suitability, European Pharmacopoeia (EP) Reference Standard